Revision Therapeutics, Inc.

Get Full Access

Description

  • ReVision Therapeutics is an ophthalmic biopharmaceutical company developing a novel, small-molecule drug for the treatment and prevention of dry age-related macular degeneration.
  • location

    Headquarters:5626 Oberlin Dr Ste 100 , San Diego, California, United States

    More
  • Revision Therapeutics, Inc. phone

    Phone Number: +1 858-348-2180

  • Revision Therapeutics, Inc. website

    Website: https://www.revisiontherapeutics.com

  • Revision Therapeutics, Inc. employees

    Employees:0

  • Revision Therapeutics, Inc. revenue

    Revenue:$0 - 1M

  • Revision Therapeutics, Inc. legal name

    Legal Name:Revision Therapeutics, Inc.

  • Revision Therapeutics, Inc.'s Social Media

    Revision Therapeutics, Inc. linkedin
  • done Is this data correct?
  • |  NAICS Code: 325412  |

    Show More
Person level website identification

Chief Scientific Officer for Revision Therapeutics, Inc.

Nathan Mata

Chief Scientific Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Nathan Mata

Chief Scientific Officer

Frequently Asked Questions regarding Revision Therapeutics, Inc.

  • Where are Revision Therapeutics, Inc.'s Headquarters?

    Revision Therapeutics, Inc.'s Headquarters are in 5626 Oberlin Dr Ste 100 ,San Diego,California,United States

  • What is Revision Therapeutics, Inc.'s phone number?

    Revision Therapeutics, Inc.'s phone number is +1 858-348-2180

  • What is Revision Therapeutics, Inc.'s official website?

    Revision Therapeutics, Inc.'s official website is https://www.revisiontherapeutics.com

  • What is Revision Therapeutics, Inc.'s Revenue?

    Revision Therapeutics, Inc.'s revenue is $0 - 1M

  • What is Revision Therapeutics, Inc.'s NAICS code?

    Revision Therapeutics, Inc.'s NAICS code is 325412

  • What is Revision Therapeutics, Inc.'s Industry?

    Revision Therapeutics, Inc. is in the industry of Pharmaceuticals

  • Who is Revision Therapeutics, Inc.'s Chief Scientific Officer?

    Revision Therapeutics, Inc.'s Chief Scientific Officer is Nathan Mata

Company Directory